A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings.
about
STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardshipHost-defense peptides with therapeutic potential from skin secretions of frogs from the family pipidaeThe Lung is a Host Defense Niche for Immediate Neutrophil-Mediated Vascular Protection.Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance studyThe absence of zoonotic agents in invasive bullfrogs (Lithobates catesbeianus) in Belgium and The Netherlands.A pseudo-outbreak due to Acinetobacter species (GIM-1) contamination of the pneumatic transport system of a Large University Hospital.Carriage of Enterobacteria Producing Extended-Spectrum β-Lactamases and Composition of the Gut Microbiota in an Amerindian CommunityProliferation and significance of clinically relevant β-lactamases.Investigation of antibiotic resistance in the genomic era of multidrug-resistant Gram-negative bacilli, especially Enterobacteriaceae, Pseudomonas and Acinetobacter.Fosfomycin for the treatment of resistant gram-negative bacterial infections. Insights from the Society of Infectious Diseases Pharmacists.Structure, toxicity and antibiotic activity of gramicidin S and derivativesBulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms.Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: A prospective randomised study.The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.Synthetic Enterobacterial Common Antigen (ECA) for the Development of a Universal Immunotherapy for Drug-Resistant Enterobacteriaceae.[Treatment of gunshot fractures of the lower extremity: Part 1: Incidence, importance, case numbers, pathophysiology, contamination, principles of emergency and first responder treatment].Infection prevention and control guideline for cystic fibrosis: 2013 update.The anti-biofilm potential of pomegranate (Punica granatum L.) extract against human bacterial and fungal pathogens.The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings?Carbapenemase-producing bacteria in patients hospitalized abroad, FranceAntibiotic treatment disrupts bacterial communities in the colon and rectum of simian immunodeficiency virus-infected macaques.Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort.Klebsiella necrotizing soft tissue infections in liver transplant recipients: a case series.Prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan.
P2860
Q28067215-3E028D1F-003D-4A36-B3A4-7B13248C47F5Q28659477-8B729030-116D-40C4-B3A0-DFAB8A9BA544Q30855831-9426D231-5434-4800-8B68-6A17DBBB1D6DQ34058137-93077C2E-782F-4A20-AC02-FB898B786CF6Q34563399-EEDA45EB-7ED9-431B-AC8C-97336F3D8AC6Q35026869-CDD8CBAA-27B3-4A1A-BBF8-6D6F8B17FE6BQ35354264-3928AE63-10CD-4ED0-A002-7CCABEE6B490Q35836598-76A401C3-6D5E-4DDD-B203-0291217F8433Q38076454-A109F0E7-BA7C-4B40-85F0-FDF23B271A8BQ38086337-59C7C1C7-FD5D-4CB1-A039-8CD4EE487BA8Q38208281-52E7CFB7-C338-438E-94A0-F502221A43BAQ38793443-2819CE1F-AA50-4EFC-A036-1EB5AB00D3B9Q40517063-698FCA02-CB7A-4C2D-88BE-DC6EA68EFA47Q40567945-184E0CB7-0523-4F53-8390-904ECCA07A38Q40706134-40641B7B-7912-44CB-95B7-BE27B119047CQ41087404-E0A97F3D-4E3B-49EF-B3F3-2A9C65A3EF2CQ41660672-9E4484EE-B6C1-46C0-BDDC-30593C572DCFQ42206103-232FFD25-EBE4-427F-A5C2-B225A360DFA4Q42252908-606ED576-B368-45DC-A95C-D7D1F85068B5Q42260135-4A22F117-527B-4D99-9E0C-10D21231C123Q42265643-BBD6E3F7-60BB-4754-B2B4-8DCA22E1C54FQ42275030-AA7E7347-0469-4659-91D8-BF27CE2E6070Q42712906-5192F3A1-C576-4D3E-8287-E6441F94AD29Q45325462-F3581962-3EA7-4E5F-85F2-F8E29976D567Q45381829-3932E3AF-645E-4F9D-A0C9-E832CFFC720EQ50894549-0BD635DD-FC06-4550-B10C-B83FE36EBDAAQ51409908-D3860831-9226-4657-B4DD-1E477398E786
P2860
A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A call for action: managing t ...... ae in the acute care settings.
@ast
A call for action: managing t ...... ae in the acute care settings.
@en
A call for action: managing t ...... ae in the acute care settings.
@nl
type
label
A call for action: managing t ...... ae in the acute care settings.
@ast
A call for action: managing t ...... ae in the acute care settings.
@en
A call for action: managing t ...... ae in the acute care settings.
@nl
prefLabel
A call for action: managing t ...... ae in the acute care settings.
@ast
A call for action: managing t ...... ae in the acute care settings.
@en
A call for action: managing t ...... ae in the acute care settings.
@nl
P1476
A call for action: managing t ...... ae in the acute care settings.
@en
P2093
Patrice Savard
P304
P356
10.1097/QCO.0B013E3283558C17
P50
P577
2012-08-01T00:00:00Z